ASX Share rice
Wed 05 Aug 2020 - 11:11:am (Sydney)

BOT Share Price

BOTANIX PHARMACEUTICALS LTDBOTPharmaceuticals, Biotechnology & Life Sciences

BOT Company Information


Botanix Pharmaceuticals Limited





GIC Industry:


GIC Sub Industry:



50 Angove Street North Perth WA Australia 6006


61 8 6555 2945

Full Time Employees:


MD, Pres & Exec. Chairman:

Mr. Vincent P. Ippolito

COO & Exec. Director:

Dr. Michael Thurn Ph.D.

Chief Scientific Officer & Exec. Director:

Dr. Henry William Bosch

Exec. Director:

Mr. Matthew Callahan

Company Sec.:

Mr. Simon Robertson C.A., B.Bus, M Appl. Fin, CA

Company Overview:

Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia. It offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX 1204, a transdermal gel formation for the treatment of atopic dermatitis; BTX 1701, a novel product for mild acne; and BTX 1801, a novel antimicrobial. The company is based in North Perth, Australia.

BOT Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


BOT CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Income:


Total Cash From Operating Activities:




Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


BOT Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


BOT Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Retained Earnings:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


BOT Share Price History

BOT News

12 May, 2020
Taking the occasional loss comes part and parcel with investing on the stock market. And there's no doubt that Botanix...
13 Mar, 2020
Botanix Pharmaceuticals Limited's (ASX:BOT): Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics...
13 Jan, 2020
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
14 Nov, 2019
Botanix Pharmaceuticals Limited (ASX:BOT) shareholders might be rather concerned because the share price has dropped...